Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a
E. L. Blanchard, D. Vanover, S. S. Bawage, P. M. Tiwari, L. Rotolo, J. Beyersdorf, H. E. Peck, N. C. Bruno, R. Hincapie, M. G. Finn, F. Michel, E. R. Lafontaine, R. J. Hogan, C. Zurla, P. J. Santangelo
This study uses mRNA-encoded Cas13a to target and reduce influenza and SARS-CoV-2 RNA in vitro and in a mouse model, showing potential for therapeutic applications.
bioRxiv · Apr 24, 2020 · PreprintBioengineering